Literature DB >> 15145450

Serum steroid hormones, sex hormone-binding globulin concentrations, and urinary hydroxylated estrogen metabolites in post-menopausal women in relation to daidzein-metabolizing phenotypes.

Cara L Frankenfeld1, Anne McTiernan, Shelley S Tworoger, Charlotte Atkinson, Wendy K Thomas, Frank Z Stanczyk, Santica M Marcovina, David S Weigle, Noel S Weiss, Victoria L Holt, Stephen M Schwartz, Johanna W Lampe.   

Abstract

Equol and O-desmethylangolensin (O-DMA) are products of bacterial metabolism of daidzein, an isoflavone in soybeans; thus, the presence or absence of equol and/or O-DMA in urine is a marker of particular intestinal bacteria profiles. Plasma hormone concentrations may be lower in pre-menopausal women who harbor the bacteria capable of producing equol (equol producers) compared to women who do not (equol non-producers). We evaluated concentrations of serum hormones, sex hormone-binding globulin (SHBG), and urinary 2-hydroxyestrone (2-OH E(1)) and 16alpha-hydroxyestrone (16alpha-OH E(1)) in relation to equol-producer and O-DMA-producer phenotypes in 89 post-menopausal women. Follicle stimulating hormone (FSH) was 23% greater in O-DMA-producers compared to non-producers (P = 0.04). No significant differences in serum estrogens, androgens, metabolic hormones, or SHBG were observed in relation to either daidzein-metabolizing phenotype. Compared with non-producers within each phenotype, age-adjusted 2-OH E(1):16alpha-OH E(1) was 27% greater (P = 0.06) in equol-producers and 9% greater (P > 0.10) in O-DMA-producers, and 2-OH E(1) concentrations were 24% greater in equol producers (P = 0.07) and 42% greater in O-DMA producers (P = 0.02). No significant differences in 16alpha-OH E(1) were observed in relation to either phenotype. These results suggest that interindividual variability in intestinal bacteria may be related to differences in products of hormone metabolism in post-menopausal women.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15145450     DOI: 10.1016/j.jsbmb.2004.01.006

Source DB:  PubMed          Journal:  J Steroid Biochem Mol Biol        ISSN: 0960-0760            Impact factor:   4.292


  10 in total

Review 1.  Immune homeostasis, dysbiosis and therapeutic modulation of the gut microbiota.

Authors:  C T Peterson; V Sharma; L Elmén; S N Peterson
Journal:  Clin Exp Immunol       Date:  2015-03       Impact factor: 4.330

Review 2.  Does equol production determine soy endocrine effects?

Authors:  Dana Shor; Thozhukat Sathyapalan; Stephen L Atkin; Natalie J Thatcher
Journal:  Eur J Nutr       Date:  2012-02-25       Impact factor: 5.614

3.  Obesity prevalence in relation to gut microbial environments capable of producing equol or O-desmethylangolensin from the isoflavone daidzein.

Authors:  C L Frankenfeld; C Atkinson; K Wähälä; J W Lampe
Journal:  Eur J Clin Nutr       Date:  2014-02-26       Impact factor: 4.016

4.  Metabolomics profiles of premenopausal women are different based on O-desmethylangolensin metabotype.

Authors:  Cara L Frankenfeld; Gertraud Maskarinec; Adrian A Franke
Journal:  Br J Nutr       Date:  2021-11-12       Impact factor: 4.125

Review 5.  O-desmethylangolensin: the importance of equol's lesser known cousin to human health.

Authors:  Cara L Frankenfeld
Journal:  Adv Nutr       Date:  2011-06-28       Impact factor: 8.701

6.  Impact of dose, frequency of administration, and equol production on efficacy of isoflavones for menopausal hot flashes: a pilot randomized trial.

Authors:  Sybil L Crawford; Elizabeth A Jackson; Linda Churchill; Johanna W Lampe; Katherine Leung; Judith K Ockene
Journal:  Menopause       Date:  2013-09       Impact factor: 2.953

7.  Soy consumption during menopause.

Authors:  S Bolca; M Bracke; H Depypere
Journal:  Facts Views Vis Obgyn       Date:  2012

Review 8.  Effect of S-equol and Soy Isoflavones on Heart and Brain.

Authors:  Akira Sekikawa; Masafumi Ihara; Oscar Lopez; Chikage Kakuta; Brian Lopresti; Aya Higashiyama; Howard Aizenstein; Yue-Fang Chang; Chester Mathis; Yoshihiro Miyamoto; Lewis Kuller; Chendi Cui
Journal:  Curr Cardiol Rev       Date:  2019

9.  Urinary equol levels are positively associated with urinary estradiol excretion in women.

Authors:  Tomoko Fujitani; Yukiko Fujii; Zhaoqing Lyu; Mariko Harada Sassa; Kouji H Harada
Journal:  Sci Rep       Date:  2021-09-30       Impact factor: 4.379

10.  Isoflavone metabolism and bone-sparing effects of daidzein-metabolites.

Authors:  Mariko Uehara
Journal:  J Clin Biochem Nutr       Date:  2013-05-01       Impact factor: 3.114

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.